MONDAY 25 SEPTEMBER

HMI-001 Development of practice recommendations for potential drug disease interactions in patients with pulmonary hypertension
Mrs Emma De Ruiter1, Mrs S Gipmans2, Mrs MME Diesveld1, Mrs. B Koch2, Mr. A van Dijk3, Mr SD Borgsteede1
1Health Base Foundation, Houten , Netherlands, 2Royal Dutch Pharmacists Association (KNMP), The Hague, Netherlands, 3Radboud University Medical Centre , Nijmegen, Netherlands

HMI-002 Management of adverse drug reactions to biologicals and the support by alerts in electonic prescribing systems
Mrs Emma De Ruiter1, Mr Maurits S van Maaren2, Mr. Reda Harmane3, Mr SD Borgsteede1
1Health Base Foundation, Houten, Netherlands, 2Erasmus Medical Centre, Rotterdam, Netherlands, 3Royal Dutch Pharmacist Association (KNMP), The Hague, Netherlands

HMI-003 Efficacy and safety of molnupiravir treatment for COVID-19: a systematic review and meta-analysis of randomized controlled trials
Dr Fangyuan Tian1
1West China Hospital, Sichuan University, Chengdu, China

HMI-004 Uncertain Covid-19 messages: The perspectives of rural older adults
Dr. Hung Nguyen1, Ms. Anchanah Jeyamohan1, Dr Feng Chang1
1University Of Waterloo, Waterloo, Canada

HMI-005 Recommendations for safe medication use in patients with cirrhosis
Dr Sander Borgsteede1, MD Maridi Aerts
1Health Base Foundation & Royal Dutch Pharmacists Association, Houten, Netherlands, 2Royal Dutch Pharmacists Association, Den Haag, Netherlands

HMI-006 Optimisation of prescription drug labels: The patient’s perspective
Dr Sander Borgsteede1,2, BSc Eline Poulussen1, MSc Lisse Commandeur1
1Health Base Foundation , Houten, Netherlands, 2Royal Dutch Pharmacists Association, Den Haag, Netherlands

HMI-008 Your PAAL; evaluation of an after-hours pharmacist advice line on emergency department usage
Mrs Anna Barwick1,2, Dr Christopher Freeman1, Professor Anthony Smith1, Associate Professor Liam Caffery1
1University of Queensland, Brisbane, Australia, 2University of New England, Armidale, Australia

HMI-009 Association between participating in drug abuse prevention activities and drug abuse among African American aged 10-24 years.
Dr. Anthonia Ifeyinwa Dunkwu1
1National Agency For Food & Drug Administration & Control (nafdac), Lagos, Nigeria

HMI-010 What if patients can update shared digital medication records in partnership with healthcare professionals? A qualitative co-design study
Mr Benjamin Bugnon1,2, Pr Pascal Bonnabry2,3, Dr Christian von Plessen4,5
1Association CARA, Lausanne, Switzerland, 2University of Geneva, Geneva, Switzerland, 3Pharmacy of the University Geneva Hospitals, Geneva, Switzerland, 4Direction Générale de la Santé de l’Etat de Vaud, Lausanne, Switzerland, 5Center for Primary Care and Public Health (Unisanté), Lausanne, Switzerland

HMI-011 What’s next after medication instruction videos in Malaysian Sign Language?
Focus areas to improve medication literacy among deaf patients in University of Malaya Medical Centre (UMMC).
Madam Nur Azrida Azhari Wasi1, Ms Ching Wern Chong2
1University of Malaya Medical Centre, Kuala Lumpur, Malaysia, 2University of Malaya Medical Centre, Kuala Lumpur, Malaysia

HMI-012 Medicine and vaccine investigation and surveillance: How we do pharmacovigilance in Australia
Ms Deborah Greenbaum1, Mrs Renae Mura1
1Therapeutic Goods Administration – Department of Health and Aged Care, Majura, Australia

HMI-013 Have clinical pharmacist reviews at the University of Otago School of Pharmacy Clinic improved patient outcomes?
Professor Carlo Marra1, Dr Dhanya Nair1, Mrs Emma Smith1, Ms Tara Wheeler1, Lauren Smith1
1University Of Otago, Dunedin, New Zealand

HMI-014 A web database providing probiotics practice reference information for pharmacists and other healthcare professionals – its conception, development and preliminary evaluation
Dr Eng-Hui Chew1, Mr Adison Goh2, Dr Kevin Yap3, Ms Brigitta Budijono1, Ms Christine Lim1
1Department of Pharmacy, National University of Singapore, Singapore, Singapore, 2Group Health Informatics, National Healthcare Group, Singapore, Singapore, 3Department of Pharmacy, Singapore General Hospital, Singapore, Singapore

HMI-015 The impact of repeated interventions on improving the use of medicines and health services: successes from the Veterans’ Medicines Advice and Therapeutics Education Services program
Dr Gizat Kassie1
1Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, Australia

HMI-016 Access to essential medicines through essential medicines list-case of Kosovo
Ms Granita Selimaj1
1Kosovo Medicines Agency, Pristina, Kosovo, 2Lindita Avdyli-Health Insurance Fund, Pristina, Kosovo, 3Arbenita-Avdyli-CVS Pharmacy-USA, Macomb, USA

HMI-017 Views, barriers, and facilitators of human immunodeficiency virus -infected individuals, doctors and nurses regarding the use of a mobile health application to improve self-management in HIV-infected individuals
Ms Wen Wei Chung1, Prof Pauline Lai, Associate Professor Sasheela A/P Sri La Sri Ponnampalavanar, Associate Professor Thiam Kian Chiew
1UNIVERSITY MALAYA MEDICAL CENTER (UMMC), KUALA LUMPUR, Malaysia

HMI-018 An exploration of the timeliness of dopaminergic medicines administration in care homes using an electronic Medicines Administration (eMAR) database
Dr Mathew Smith1, Miss Fiona Headley
1Cardiff University, Cardiff, United Kingdom

HMI-020 Implementation of a project to increase knowledge about the MSc in Pharmaceutical Sciences and the Pharmacy Profession in high schools – preliminary results
Ms Bruna Romoaldo1,2, Ms Carolina Simão1,2, Ms Laura Moura1,2, Mrs Camilo Rebelo1,2, Ms Cátia Caneiras1,2,3,4,5, Mrs Luís Lourenço1,2
1Portuguese Pharmaceutical Society, Lisbon, Portugal, 2Centre of Studies for the Pharmacy Profession, Portuguese Pharmaceutical Society, Lisbon, Portugal, 3Microbiology Laboratory in Environmental Health, Institute of Environmental Health, Associate Laboratory TERRA, Faculty of Medicine, University of Lisbon, , , 4Egas Moniz Center for Interdisciplinary Research (CiiEM), Egas Moniz School of Health and Science, , , 5Institute of Preventive Medicine and Public Health, Faculty of Medicine, University of Lisbon,

TUESDAY 26 SEPTEMBER

HMI-021 Barriers and facilitators to integrating deprescribing recommendations into clinical practice guidelines: a qualitative study
Dr Emily Reeve1,2, Deanna Mill2,3, Shin Liau1, Selina Leung1, A/Prof Danijela Gnjidic4, Dr Danielle Pollock5, Dr Nagham Ailabouni2,6, Dr Wade Thompson7, Dr Frank Moriarty8, Dorsa Maher2, Dr Barbara Farrell9
1Monash University, Melbourne, Australia, 2University of South Australia, Adelaide, Australia, 3University of Western Australia, Perth, Australia, 4University of Sydney, Sydney, Australia, 5University of Adelaide, Adelaide, Australia, 6University of Queensland, Brisbane, Australia, 7University of British Columbia, Vancouver, Canada, 8Royal College of Surgeons in Ireland, Dublin, Ireland, 9Bruyère Research Institute, Ottawa, Canada

HMI-022 Application of Internet + pharmacy consultation model during the epidemic of COVID-19
Ms Fang Li1,2, Ms Kun Sun1,2, Mrs Weiwei Zhang1,2, Ms. Jing Tang1,2, Ms Huijie Meng1,2, Professor Chientai Mao1,2, Mr Chao Ai1,2
1School of Clinical Medicine, Tsinghua University, Beijing, China, 2Tsinghua Changgung Hospital, Beijing, China

HMI-023 Managing medications during ‘sick days’ in patients with chronic conditions: A theory-informed approach to intervention design
Dr Kaitlyn E Watson1, Dr Kirnvir Dhaliwal2, MS Eleanor Benterud2, MS Sandra Robertshaw2, MS Nancy Verdin2, MS Ella McMurtry2, MS Nicole Lamont2, Ms Kelsea Drall2, MS Sarah Gill2, Dr David Campbell2,4, Dr Kerry McBrien4,5, Prof Ross Tsuyuki1,6, Dr Neesh Pannu3, Dr Matthew James2,4, Dr Maoliosa Donald2,4
1EPICORE Centre, Department of Medicine, University of Alberta, Edmonton, Canada, 2Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada, 3Division of Nephrology, Department of Medicine, University of Alberta, Edmonton AB, Canada , Edmonton, Canada, 4Department of Community Health Sciences, University of Calgary, Alberta, Canada, Calgary, Canada, 5Department of Family Medicine, University of Calgary, Alberta Canada, Calgary, Canada, 6Departments of Pharmacology, University of Alberta, Edmonton, AB. Canada, Edmonton, Canada

HMI-024 Adverse events associated with vericiguat : An analysis of FAERS database
Ms Kun Sun1,2, Ms Yan Yan1,2, Ms Huijie Meng1,2, Ms. Jing Tang1,2, Mr Chao Ai1,2, Mr Chientai Mao1,2
1Tsinghua Changgung Hospital, Beijing, China, 2School of Clinical Medicine,Tsinghua University, Beijing, China

HMI-025 Pharmacists’ pivotal roles in responding to novel healthcare communications
Ms Luh Rai Maduretno Asvinigita1
1Young Experts Tech For Health (YET4H), Basel , Switzerland, 2Indonesian Young Pharmacists Group (IYPG), Jakarta, Indonesia

HMI-026 Pediatric treatment satisfaction with medication measurement research and related evaluation tool: a systematic review
Ms Mengting Yang1,2,3,4,5, Ms Shuya Zhang6, Ms Xiaorui Ji6, Ms Weiyi Yan6, Dr. Kun Zou1,2,3,4, Pro Zhijun Jia1,2,3,4,6, Pro Guo Cheng4,7,8, Pro Linan Zeng1,2,3,4, Pro Lingli Zhang1,2,3,4,9
1Department of Pharmacy, West China Second University Hospital, Sichuan Universit, Chengdu, China, 2Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China, 3NMPA Key Laboratory for Technical Research on Drug Products In Vitro and In Vivo Correlation, Chengdu, China, 4Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China, 5West China School of Medicine, Sichuan University, Chengdu, Chengdu, China, 6West China School of Pharmacy, Sichuan University, Chengdu, China, 7Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China, 8Laboratory of Molecular Translational Medicine, Center for Translational Medicine, Sichuan University, Chengdu, China, 9Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, China

HMI-027 Preparing for climate change: The essential role of pharmacy in addressing the next global crisis
Mr Murray Aitken1
1IQVIA Institute For Human Data Science, Parsippany, United States, 2London School of Economics, London, England

HMI-028 Outlook for medicines use and spending through 2027: Impact on the pharmacy sector
Mr Murray Aitken1
1IQVIA Institute For Human Data Science, Parsippany, United States, 2London School of Economics, London, England

HMI-029 Categorization of global digital health resources to empower educators and practitioners
Prof Hoai-An Truong1, Dr. See-Won Seo2, Dr. Nisreen Mourad, Dr Abby Kahaleh
1University of Maryland Eastern Shore, Derwood, United States, 2Albany College of Pharmacy and Health Science, Albany, United States, 3Lebanese International University, Bekaa, Lebanon, 4Roosevelt University College of Science, Health, & Pharmacy, Chicago, United States

HMI-030 Pilot project demonstrating the role of community pharmacist in outpatient setting in India.
Dr Jinesh Bahubali Nagavi1, Ms Krishna Kumar Sahana1, Ms Shivamallaih Lakshmi1, Prof Chandra Sekar2
1Sarada Vilas College of Pharmacy, Mysuru, Karnataka, India, 2College of Pharmacy, University of Findlay, Findlay, Ohio, USA

HMI-031 A review of acute paediatric pain guidelines in Australian hospitals
Mrs Joanne Shalala1, Bana Moussa1, Brett MacFarlane2, Karalyn Huxhagen3, Dr Yetunde Kolade1
1Reckitt, Sydney, Australia, 2PanwarHealth, Brisbane, Australia, 3Consultant Pharmacist, Mackay, Australia

HMI-032 List of Australian potentially inappropriate medicines – the AUS-PIMs List
Dr Kate Wang1,2,3, Dr, Amy Page3,4, Associate Professor Frank Sanfilippo3, Professor Christopher Etherton-Beer3,4
1School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia, 2Pharmacy department, Alfred Health, Melbourne, Australia, 3School of Allied Health, University of Western Australia, Perth, Australia, 4Western Australian Centre for Health and Ageing, University of Western Australia, Perth, Australia

HMI-033 I do not understand asthma: a qualitative exploration of asthma management among Middle Eastern Arabic speaking refugees and migrants.
Mrs Malath Jamal Jaafar Al-juhaishi1, Dr Vincent Chan, Professor Ieva Stupans, Dr Chiao Xin Lim, Dr Thilini Thrimawithana
1RMIT University, Melbourn, Australia

HMI-034 The Covid-19 andemic perspective from a New Zealand medicines information service
Mrs Marie-Claire Morahan1, Mr Duncan Yorkston1, Mrs Julie Knight1, Ms Tracey Borrie1, Mr Bruce Hastie1, Dr Paul Chin1,2
1Department of Clinical Pharmacology, Te Whatu Ora, Waitaha, Health New Zealand, Christchurch, New Zealand, 2Department of Medicine, University of Otago, Christchurch, New Zealand

HMI-035 Oral direct factor Xa inhibitor-related vasculitis: Analysis of the FDA Adverse Event Reporting System (FAERS) data and literature review
Ms Min Luo1, Ms Hao Li1,2, Ms Yihan Liu1,2, Mr Bin Wu1
1West China Hospital, Sichuan University, Chengdu City, Sichuan Province, China, 2West China School of Pharmacy, Sichuan University, Chengdu City, Sichuan Province, China

HMI-036 Propionic acid derivatives improve cardiovascular disease in patients with diabetes
Ph.D. Chen-Sheng Chen1,3, Ph.D. Bo-Yi Pan2, Ph.D. Yu-Ting Hsu2, Ph.D. Fang-Yu Chen2, Prof Wen-Chin Yang4, Prof Ming-yi Shen2,5
1The Ph.D. Program for Cancer Biology and Drug Discovery, China Medical University and Academia Sinica, Taichung, Taiwan China, 2Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan China, 3Taichung City Pharmacists’ Association, Taichung, Taiwan China, 4Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan China, 5Department of Medical Research, China Medical University Hospital, Taichung, Taiwan China

WEDNESDAY 27 SEPTEMBER

HMI-040 Artificial intelligence in the management of cardiovascular disease
Mr Jean Pierre Galea1, Dr Francesca Wirth1, Prof Lilian M. Azzopardi1
1Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta

HMI-041 Comparative analysis of antibiotic prescribing at the time of sore throat in three European countries: Implications for antimicrobial resistance
MD. PhD Graça Coutinho1, Dr Aurelio Sessa2, Dr Thomas Hallett1, Mr Adrian Shephard1, Dr Martin Duerden3
1Reckitt Benckiser Healthcare Ltd, Slough, United Kingdom, 2Italian College of General Practitioners and Primary Care (Società Italiana di Medicina Generale), Florence, Italy, 3Centre for Medical Education, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom

HMI-042 Authorised medicinal products produced using recombinant DNA technology
Ms Nadia Manicaro1, Prof Anthony Serracino-Inglott1, Dr Nicolette Sammut Bartolo1
1Department of Pharmacy, University of Malta, Msida, Malta

HMI-043 Effectiveness of education and regulatory change in preventing anti-doping violations from sports supplements
Dr Naomi Speers1, Dr Jenny Cheng2, Alex Stevenson2, Kerry Knowler1, Alexis Cooper1, Prof Andrew McLachlan3
1Sport Integrity Australia, Canberra, Australia, 2Therapeutic Goods Administration, Canberra , Australia, 3University of Sydney, Sydney, Australia

HMI-044 The pharmacoeconomics of Covid-19: Effects on access to medicines and universal health coverage in Nigeria.
Mr Otuto Amarauche Chukwu1
1University Of Toronto, Toronto, Canada

HMI-045 SELF-Rx: A digital application to monitor patients’ adherence in the practice of self-medication and a clinical reference tool for pharmacists in the provision of self-medication therapy in Indonesia
Ms. Patricia Heidi Surjadidjaja1
1International Pharmaceutical Students’ Federation, Jakarta Utara, Indonesia

HMI-046 Impact of interventions on medication adherence in patients with coexisting diabetes and hypertension
Ms Pauline Tendai Maniki1, Prof Parisa Aslani, Prof Betty Chaar
1The University Of Sydney School of Pharmacy, Faculty of Medicine and Health, Sydney , Australia

HMI-047 Hospital pharmacists counselling practices in Sri Lanka: Do pharmacists need institutional support?
Ms. Rathnaweera Bopage Janani Buddhika1, Ms. Walabaduge Mahesha Chathurani1, Ms. Jayasekera RWMJP2, Ms. Wickramasinghe NDD1
1Department of Pharmacy, Faculty of Health Sciences, The Open University of Sri Lanka, Nugegoda, Sri Lanka, 2National Hospital , Kandy, Sri Lanka

HMI-048 Patient willingness to use a language learning model for questions related to medication therapy related: A quantitative survey
Lead Innovation Advisor Ravi Patel1
1University Of Pittsburgh, Pittsburgh, United States

HMI-049 Role of pharmacists in vaccination in low-and-middle-income countries before and after the Covid-19 pandemic: A multi-country survey
Ms Savannah Moody1, Mr. Tatenda Yameke1, Dr. Sachiko Ozawa1,2
1Division of Practice Advancement and Clinical Education, UNC Eshelman School of Pharmacy, Chapel Hill, NC, United States, 2Department of Maternal and Child Health, UNC Gillings School of Public Health, Chapel Hill, NC, United States

HMI-050 The impact of drug shortages on drug prices: evidence from China
Ms Shuchen Hu1,2, Mr Jinwei Zhang1,2, Mr Jianwei Li3, Ms Jieqiong Zhang1,2, Ms Mengyuan Pan1,2, Ms Cheng Xiang1,2, Prof Chintan Dave4,5, Prof Caijun Yang1,2, Dr Yu Fang1,2
1Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an, Shaanxi Province, China, 2Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an, Shaanxi Province, China, 3School of Software Engineering, Xi’an Jiaotong University, Xi’an, Shaanxi Province, China, 4Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ, USA, 5Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA

HMI-051 Issues in advanced pharmaceutical care of companion animals in Japan: an untouched field
Dr Taisuke Konno1, Dr Hiroyuki Suzuki1, Prof Hitoshi Nakamura1, Prof Yuriko Murai1
1Tohoku Medical and Pharmaceutical University, sendai, Japan

HMI-052 Assessment of the quality of drug information provided by ChatGPT to patients
Mr Wahram Andrikyan1, Frithjof Kosfeld1, Ms Lea Jung-Poppe1,2, Hagen Fabian Nicolaus1,2, Prof. Dr. Renke Maas1
1Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, 2Universitätsklinikum Erlangen, Erlangen, Germany

HMI-053 A pharmacovigilance study of the association between antipsychotic drugs and Venous thromboembolism based on Food and Drug Administration adverse event reporting system data
Ms Yu Yan1
1West China Hospital, Chengdu, China

HMI-053 Creation of the ew meds list – A comprehensive list of poor tasting liquid medications
Dr Amy Kruger Howard1, Dr Jill Ann Morgan1
1University Of Maryland School Of Pharmacy, Baltimore, United States